Shattuck Labs: 'Hold' On Phase 1 SL-325 Data And Next Stage Of Development

Shattuck Labs (STTK) holds steady as SL-325 shows strong Phase 1 data; Phase 2b Crohn’s trial starts Q3 2026. Read here for a ...